Skip to main content
Sofosbuvir tied to kidney improvement for some patients

A Brazilian study in the Journal of Clinical Pharmacy and Therapeutics found sofosbuvir-based treatment demonstrated a 98.9% rate of sustained virological response among patients with chronic hepatitis C virus and a significant improvement in renal biomarkers among those with mild or moderate renal impairment. The findings were based on data for 94 patients.

Full Story: